Hsp90 inhibitors reduce influenza virus replication in cell culture

Geoffrey Chase1, Tao Deng, Ervin Fodor

  • 1Department of Virology, Institute for Medical Microbiology and Hygiene, University of Freiburg, Hermann-Herder-Strasse 11, D-79104 Freiburg, Germany.

Virology
|June 24, 2008
PubMed

Insights

Heat shock protein 90 (Hsp90) inhibitors delay influenza A virus growth by disrupting viral polymerase complex assembly. This suggests Hsp90 inhibitors are a potential new class of antiviral drugs against influenza.

Area of Science:

  • Virology
  • Molecular Biology
  • Drug Discovery

Background:

  • Influenza A virus polymerase complex comprises PB1, PB2, and PA subunits.
  • Cellular chaperone Hsp90 aids polymerase complex nuclear import and assembly by binding PB1 and PB2.

Purpose of the Study:

  • To investigate the effect of Hsp90 inhibitors on influenza A virus replication.
  • To explore Hsp90 inhibitors as potential antiviral agents.

Main Methods:

  • Utilized Hsp90 inhibitors (geldanamycin, 17-AAG) in cell culture.
  • Assessed viral growth and viral titre.
  • Examined the impact on polymerase subunit stability and nuclear import.

Main Results:

  • Hsp90 inhibitors reduced influenza virus titre by 1-2 logs early in infection.
  • Inhibitors decreased the half-life of PB1 and PB2 subunits.
  • Nuclear import of PB1 and PA was inhibited, impairing viral RNP assembly.

Conclusions:

  • Hsp90 inhibition disrupts influenza virus replication by affecting polymerase complex formation.
  • Hsp90 inhibitors demonstrate potential as a novel antiviral strategy against influenza viruses.

Related Concept Videos

Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Inhibitors of Viral Protein Synthesis01:30

Inhibitors of Viral Protein Synthesis

Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...